Search results for "eppendorf"
Selected Filters:
AliveDx’s MosaiQ gains FDA Class II 510(k) exempt device status
The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions
How to Buy Analytical Technology for Cell Line Development
As cell line development (CLD) programs grow in complexity and scale, with increasing demands for speed, data quality, and adaptability, it is essential to choose the right analytical tools that will future-proof your workflow.
Trailblazing earlier diagnosis of multiple myeloma for better patient outcomes
Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific
How advocacy shaped the regulation of laboratory-developed tests
Laboratory leaders are turning to rapid AST to advance antimicrobial stewardship
With antimicrobial resistance on the rise, rapid AST offers a lifeline for critically ill patients and supports improved antibiotic stewardship
Firefly application note: Illumina DNA Prep
ADLM leads strategic initiatives to address the clinical laboratory workforce shortage
MGB:EDQ probes for qPCR
How external quality controls are transforming molecular diagnostics
Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics
Ultima Genomics' ppmSeq delivers unmatched combination of sensitivity and efficiency for whole-genome MRD detection
With its unique combination of low-cost and high accuracy, ppmSeq marks a real breakthrough in sequencing technology
VELSSON consumables
LGC Standards' role in nitrosamine detection
Calibrex bottle-top dispensers: The reliable choice
The Optimer Discovery Platform
INNOSMART liquid handling systems
Overcome common and costly pitfalls in complex clinical diagnostics development
Quantitative proteomics advances disease modeling and drug development
Learn how Inotiv’s proteomics services are helping researchers gain deeper insights into drug target systems, to better select disease models, and quantify pathology data
BioMed X and Novo Nordisk launch new collaboration in oral peptide drug delivery
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists